Inflammation and resolution in exercise-induced skeletal muscle injury: The effect of NSAID treatment on pro-inflammatory and anti-inflammatory/pro-resolving lipid mediators. by Markworth, James F et al.
   11th ISEI SYMPOSIUM, NEWCASTLE, AUSTRALIA, 9-12 September 2013   
   Exercise Immunology: Prescriptions for Health 
  ABSTRACT FORM 
 
 
This form should be read in conjunction with the ISEI ABSTRACT GUIDELINES.  
 
These 2 pages have been provided separately to assist you with the submission of your 
Abstracts in Word format to the Conference Organising Committee and online to the 
International Journal of Exercise Science (IJES). 
 
You MUST complete this entire Abstract Form to provide us with details needed to assign 
your abstract to the correct theme. 
 
Also advise us if you are applying to be considered for one of the Early Career Researcher 
Awards (Best Poster and Best Oral Presentation). 
 
Send this entire form by E-mail to the ISEI Organising Committee, but ALSO follow the 
guidelines for submission of the Abstract (single page only) to the IJES. 
 





Title (up to 30 words, Arial, 11 pt, 
single line spaced, in sentence 
case. Like this:  
Inflammation and resolution in exercise-induced 
skeletal muscle injury: The effect of NSAID treatment 
on pro-inflammatory and anti-inflammatory/pro-
resolving lipid mediators  
 
Authors (Underline the presenting 
author) 
 
J Markworth, L Vella, K Maddipati & D Cameron-Smith 
 
 
Department, Institution, Country 
 
 
Liggins Institute, University of Auckland, New Zealand 
 
Address Corresponding Author 
 
 
19 Carlton Gore Road, Grafton 1023, Auckland, New 
Zealand 
 
Select Your Abstract Session 
Theme Category 
7 Clinical prescriptions for exercise in athletes – 
what are the key messages for prevention of illness 
and adequate recovery for athletic populations? 
Preferred Presentation Form      
 
×Oral communication     Poster  
 
Note final decisions on format of presentation will be 
by the ISEI Scientific Committee 
Is the presenter eligible for the 
Early Career Researcher Awards 
(poster and oral awards)?   
 
(Previous winners are ineligble for 
same category) 
 
× Yes     No 
 
Eligible persons are those studying for a higher 
degree – MSc, MPhil or PhD – or who have 
completed their PhD within the last 3 years as at 10th 
September 2013 
ISEI Abstract – 
“Clinical prescriptions for exercise in athletes- What are the key 
messages for prevention of illness and adequate recovery for athletic 
populations. Session theme number – 7” 
 
Inflammation and resolution in exercise-induced skeletal muscle 
injury: The effect of NSAID treatment on pro-inflammatory and anti-
inflammatory/pro-resolving lipid mediators. 
 
Markworth JF1, Vella L2, Maddipati K3, and Cameron-Smith D1.  
 
1 Liggins Institute, The University of Auckland, Auckland, New Zealand 
2 School of Exercise and Nutrition Sciences, Deakin University, Victoria, Australia 
3 Bioactive Lipids Research Program, Department of Pathology, School of Medicine, 




Current approaches in the treatment of exercise-induced muscle injury rely on the inhibition of pro-inflammatory 
pathways to alleviate cardinal signs of inflammation; redness, swelling, heat and pain. However,  recent research 
suggests that the cellular events which occur early in acute inflammation engage an active and coordinated 
inflammatory resolution program characterised by a switch from pro-inflammatory mediators to production of 
active pro-resolution factors that govern the withdrawal of inflammation whilst facilitating tissue healing. This 
led to the identification of novel classes of anti-inflammatory/pro-resolving lipid mediators, including the 
lipoxins (LX), resolvins (Rv), and protectins (P), which may provide new targets in the treatment of inflammation. 
METHODS: Sixteen untrained male subjects (age 23±0.7yr, mass 88±3.1kg) were assigned to a placebo (PLA) 
(n=8) or ibuprofen (IBU) (n=8) group. Subjects completed a single bout of resistance exercise consisting of 3 sets of 
8-12 repetitions of a squat, leg press and leg extensions at 80% 1RM. Intravenous blood samples were obtained at 
rest, at 30 min intervals between 0 and 3 h and again at 24 h post exercise. The IBU group orally consumed 400mg 
of the non-steroidal anti-inflammatory drug (NSAID) ibuprofen pre-exercise, and again at 5 and 10 h post 
exercise (1200 mg/day). Serum lipid mediator profiles were analysed via LC-MS targeted lipidomics. RESULTS: 
Acute exercise increased serum levels of pro-inflammatory eicosanoid species derived from both the COX-1 and 2 
(prostaglandins: e.g. PGF2α, PGE2, PGD2, TXB2) and 5-LOX (leukotrienes: e.g. LTB4, LTB5) pathways. Additionally, 
heightened circulating levels of novel pro-resolving lipid mediators derived from arachidonic acid (LXA4 and 
LXB4), EPA (RvE1) and DHA (RvD1 and PD1 isomer) were detected post-exercise. Both the pro-inflammatory 
COX-1 & 2/5-LOX responses, as well as pro-resolving lipid mediator biosynthesis were blunted by the 
administration of the COX-1 and 2 inhibiting NSAID ibuprofen. CONCLUSION: Pro-inflammatory eicosanoids 
as well as novel pro-resolving bioactive lipid mediators are acutely up regulated following unaccustomed 
resistance exercise; a response which is diminished by IBU treatment. We hypothesize that the active resolution of 
exercise-induced inflammation may be important in effective post-exercise recovery and that a shift from anti-
inflammatory interventions towards those which promote active resolution may hasten natural withdrawal of 
inflammation whilst facilitating the successful repair and regeneration of damaged muscle tissue. 
  
